Zoetis
ZTS
135,52 €
Share price
0.05%
Change (1 day)
-15.54%
Change (1 year)
Categories
Revenue for Zoetis (ZTS)
Revenue in 2025 (TTM): €8.62 Billion
According to Zoetis's latest financial reports the company's current revenue (TTM 
) is €7.97 Billion. In 2024 the company made a revenue of €8.89 Billion an increase over the revenue in the year 2023 that were of €7.72 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zoetis from 2011 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | €8.62 B | -3.07% |
| 2024 | €8.89 B | 15.08% |
| 2023 | €7.72 B | 2.61% |
| 2022 | €7.53 B | 9.71% |
| 2021 | €6.86 B | 26.52% |
| 2020 | €5.42 B | -2.89% |
| 2019 | €5.58 B | 9.75% |
| 2018 | €5.09 B | 15.12% |
| 2017 | €4.42 B | -4.82% |
| 2016 | €4.64 B | 6.63% |
| 2015 | €4.35 B | 10.77% |
| 2014 | €3.93 B | 19.13% |
| 2013 | €3.30 B | 0.75% |
| 2012 | €3.27 B | 0.57% |
| 2011 | €3.25 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | €42.06 B | 427.71% | 🇺🇸 USA |
 Merck MRK | €54.87 B | 588.37% | 🇺🇸 USA |
 Pfizer PFE | €53.62 B | 572.66% | 🇺🇸 USA |
 Phibro Animal Health
PAHC | €1.02 B | -87.18% | 🇺🇸 USA |
 Kindred Biosciences
KIN | €6.8 M | -99.91% | 🇺🇸 USA |
 Heska Corporation
HSKA | €0.21 B | -97.26% | 🇺🇸 USA |
 Sanofi SNY | €40.69 B | 410.43% | 🇫🇷 France |